It has emerged recently that SDHB immunoreactivity is tightly correlated with mutational status in GIST such that mutant cases are consistently SDHB-immunopositive while WT cases are frequently SDHB-immunonegative, notably in the pediatric setting [13], [14]. Here, SDHB is linked to gastrointestinal stromal tumor.